Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-13

Clinical Trial Update: Diphenhydramine and Sweating [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing diphenhydramine-related adverse effects including hyperthermia and sweating in therapeutic use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenhydramine (diphenhydramine)

Snippet

Sponsor: Lakehead University | Conditions: Diphenhydramine Causing Adverse Effects in Therapeutic Use, Hyperthermia | Phase 4 | Status: COMPLETED